Haruki Kaku
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety and efficacy of Rezūm water vapour energy therapy in BPH patients receiving antithrombotic therapy: A Japanese single-centre experience.
Journal: BJUI compass
Published: December 13, 2025
Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 24, 2015
A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model.
Journal: Oncotarget
Published: November 30, 2014
Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene.
Journal: Molecular biotechnology
Published: February 15, 2014
Clinical significance of CD24 as a predictor of bladder cancer recurrence.
Journal: Oncology letters
Published: November 28, 2012
Cancer stem cell-like characteristics of a CD133+ subpopulation in the J82 human bladder cancer cell line.
Journal: Molecular and clinical oncology
Published: May 30, 2012
Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy.
Journal: Oncology reports
Published: April 09, 2012
Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.
Journal: Acta medica Okayama
Published: February 24, 2012
REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
Journal: International journal of oncology
Published: January 13, 2012
Last Updated: 09/26/2026